Disclosures for "CREXONT® (IPX203, ER CD-LD) Super-responders: Enhanced Symptom Control in Parkinson’s Disease"
-
Dr. Allard has received personal compensation for serving as an employee of Amneal.
-
Dr. Banisadr has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
-
Dr. Fisher has received personal compensation for serving as an employee of Amneal Pharmaceuticals.
-
Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. LeWitt has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ONO Pharmaceuticals. Dr. LeWitt has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. The institution of Dr. LeWitt has received research support from Michael J Fox Foundation.